{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:15:15Z","timestamp":1784931315720,"version":"3.55.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UI\/BD\/151344\/2021"],"award-info":[{"award-number":["UI\/BD\/151344\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In addition to evidence supporting the use of psychedelics in treating alcohol and tobacco misuse, emerging research suggests that psychedelic experiences may also facilitate beneficial changes in other health behaviors, such as diet, exercise, and meditation. This retrospective, survey-based study explored perceived health behavior changes following psychedelic experiences, from the perspective of 96 psychedelic practitioners, working in both legal and underground contexts. Practitioners reported on perceived changes in their clients\u2019 or patients\u2019 behaviors, including physical activity, diet and nutrition, contemplative practices, and time spent in nature, as well as on their own behavior changes, and potential mechanisms underlying these changes. Behaviors with the highest proportion of clients perceived as having changed in a positive direction included contemplative practices (61.4%), time spent in nature (60.1%), eating patterns (56.9%), and diet and nutrition (56%). These findings suggest that practitioners often perceive psychedelic experiences as associated with positive health behavior change. Future research is needed to validate these findings, explore the extent and mechanisms of potential changes, and assess whether such effects are sustained over the long-term. Understanding these effects may help inform future behavior change interventions and public health policy.<\/jats:p>","DOI":"10.1038\/s41598-025-25818-3","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:46:20Z","timestamp":1764081980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring practitioners\u2019 perceptions of health behavior changes associated with psychedelic experiences"],"prefix":"10.1038","volume":"15","author":[{"given":"Laura C.","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Encantado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"van Elk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlen C.","family":"Moller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talea","family":"Cornelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Timmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo","family":"Veiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro J.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"1","key":"25818_CR1","first-page":"112","volume":"8","author":"K Hacker","year":"2024","unstructured":"Hacker, K. The burden of chronic disease. Mayo Clin. Proceedings: Innovations Qual. Outcomes. 8 (1), 112\u2013119 (2024).","journal-title":"Mayo Clin. Proceedings: Innovations Qual. Outcomes"},{"key":"25818_CR2","unstructured":"World Health Organization (2024). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/noncommunicable-diseases"},{"key":"25818_CR3","unstructured":"World Health Organization (2025). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight"},{"key":"25818_CR4","unstructured":"World Health Organization (2025). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/tobacco"},{"key":"25818_CR5","unstructured":"World Health Organization (2024). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/physical-activity"},{"issue":"42","key":"25818_CR6","first-page":"12","volume":"6","author":"S Michie","year":"2011","unstructured":"Michie, S., van Stralen, M. M. & West, R. The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implement. Sci. 6 (42), 12\u201319 (2011).","journal-title":"Implement. Sci."},{"key":"25818_CR7","unstructured":"Michie, S., Atkins, L. & West, R. The Behavior Change Wheel: A Guide To Designing Interventions (Silverback Publishing, 2014)."},{"key":"25818_CR8","doi-asserted-by":"crossref","unstructured":"Hagger, M. S., Cameron, L. D., Hamilton, K., Hankonen, N. & Lintunen, T. The science of behavior change: the road ahead in The Handbook of Behavior Change (eds Hagger, M. S., Cameron, L. D., Hamilton, K., Hankonen, N. & Lintunen, T.) 677\u2013699 (Cambridge University Press, (2020).","DOI":"10.1017\/9781108677318.046"},{"issue":"1","key":"25818_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/02698811211008554","volume":"36","author":"PJ Teixeira","year":"2022","unstructured":"Teixeira, P. J. et al. Psychedelics and health behaviour change. J. Psychopharmacl. 36 (1), 12\u201319 (2022).","journal-title":"J. Psychopharmacl"},{"issue":"10","key":"25818_CR10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","volume":"79","author":"MP Bogenschutz","year":"2022","unstructured":"Bogenschutz, M. P. et al. Percentage of heavy drinking days following Psilocybin-Assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder. JAMA Psychiatry. 79(10), 953-962 (2022).","journal-title":"JAMA Psychiatry."},{"key":"25818_CR11","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/02791072.2019.1607956","volume":"51","author":"I Berlowitz","year":"2019","unstructured":"Berlowitz, I., Walt, H., Ghasarian, C., Mendive, F. & Martin-Soelch, C. Short-Term treatment effects of a substance use disorder therapy involving traditional Amazonian medicine. J. Psychoact. Drugs. 51, 323\u2013334 (2019).","journal-title":"J. Psychoact. Drugs"},{"key":"25818_CR12","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1177\/0269881119845793","volume":"33","author":"A Garcia-Romeu","year":"2019","unstructured":"Garcia-Romeu, A. et al. Cessation and reduction in alcohol consumption and misuse after psychedelic use. J. Psychopharmacol. 33, 1088\u20131101 (2019).","journal-title":"J. Psychopharmacol."},{"key":"25818_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/dar.13348","volume":"41","author":"D Perkins","year":"2022","unstructured":"Perkins, D. et al. Associations between Ayahuasca consumption in naturalistic settings and current alcohol and drug use: results of a large international cross-sectional survey. Drug Alcohol Rev. 41, 265\u2013274 (2022).","journal-title":"Drug Alcohol Rev."},{"issue":"1","key":"25818_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2174\/15733998113099990003","volume":"6","author":"G Thomas","year":"2013","unstructured":"Thomas, G., Lucas, P., Rielle Capler, N., Tupper, K. W. & Martin, G. Ayahuasca-Assisted therapy for addiction: results from a preliminary observational study in Canada. Curr. Drug Abuse Rev. 6 (1), 30\u201342 (2013).","journal-title":"Curr. Drug Abuse Rev."},{"key":"25818_CR15","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0269881114548296","volume":"28","author":"MW Johnson","year":"2014","unstructured":"Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P. & Griffiths, R. R. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. J. Psychopharmacol. 28, 983\u2013992 (2014).","journal-title":"J. Psychopharmacol."},{"key":"25818_CR16","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00213-022-06063-2","volume":"239","author":"D Daldegan-Bueno","year":"2022","unstructured":"Daldegan-Bueno, D., Maia, L. O., Massarentti, C. M. & T\u00f3foli, L. F. Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil. Psychopharmacology 239, 1767\u20131782 (2022).","journal-title":"Psychopharmacology"},{"key":"25818_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","volume":"43","author":"MW Johnson","year":"2017","unstructured":"Johnson, M. W., Garcia-Romeu, A. & Griffiths, R. R. Long-term follow-up of psilocybin-facilitated smoking cessation. Am. J. Drug Alcohol Abuse. 43, 55\u201360 (2017).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"25818_CR18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1177\/0269881116684335","volume":"31","author":"MW Johnson","year":"2017","unstructured":"Johnson, M. W., Garcia-Romeu, A., Johnson, P. S. & Griffiths, R. R. An online survey of tobacco smoking cessation associated with naturalistic psychedelic use. J. Psychopharmacol. 31, 841\u2013850 (2017).","journal-title":"J. Psychopharmacol."},{"key":"25818_CR19","doi-asserted-by":"crossref","unstructured":"Jones, G., Lipson, J. & Nock, M. K. Associations between classic psychedelics and nicotine dependence in a nationally representative sample. Sci Rep 12, (2022).","DOI":"10.1038\/s41598-022-14809-3"},{"key":"25818_CR20","doi-asserted-by":"crossref","unstructured":"Simonsson, O., Osika, W., Carhart-Harris, R. & Hendricks, P. S. Associations between lifetime classic psychedelic use and cardiometabolic diseases. Sci Rep 11, (2021).","DOI":"10.1038\/s41598-021-93787-4"},{"key":"25818_CR21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/0269881121996863","volume":"35","author":"O Simonsson","year":"2021","unstructured":"Simonsson, O., Sexton, J. D. & Hendricks, P. S. Associations between lifetime classic psychedelic use and markers of physical health. J. Psychopharmacol. 35, 447\u2013452 (2021).","journal-title":"J. Psychopharmacol."},{"key":"25818_CR22","doi-asserted-by":"crossref","unstructured":"Simonsson, O., Hendricks, P. S., Chambers, R., Osika, W. & Goldberg, S. B. Classic psychedelics, health behavior, and physical health. Ther Adv. Psychopharmacol 12, (2022).","DOI":"10.1177\/20451253221135363"},{"issue":"3","key":"25818_CR23","first-page":"1","volume":"55","author":"M Kohek","year":"2022","unstructured":"Kohek, M. et al. Ayahuasca and public health II: health status in a large sample of Ayahuasca-Ceremony participants in the Netherlands. J. Psychoact. Drugs. 55 (3), 1\u201312 (2022).","journal-title":"J. Psychoact. Drugs"},{"key":"25818_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/02791072.2019.1567961","volume":"51","author":"G Ona","year":"2019","unstructured":"Ona, G. et al. Ayahuasca and public health: health Status, psychosocial Well-Being, Lifestyle, and coping strategies in a large sample of ritual Ayahuasca users. J. Psychoact. Drugs. 51, 135\u2013145 (2019).","journal-title":"J. Psychoact. Drugs"},{"issue":"2","key":"25818_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","volume":"68","author":"DE Nichols","year":"2016","unstructured":"Nichols, D. E. & Psychedelics Pharmacol. Rev. 68(2), 264\u2013355 (2016).","journal-title":"Pharmacol. Rev."},{"key":"25818_CR26","unstructured":"Booking.com (2023). https:\/\/www.booking.com\/c\/trends\/travelpredictions2024.html?msockid=21ab7b2ced05617518ce6e5cec6a60ba"},{"key":"25818_CR27","unstructured":"Retreat Guru https:\/\/retreat.guru\/."},{"key":"25818_CR28","unstructured":"Hillier, D. Hedonism, healing and credible science \u2013 where next for drug tourism? (2024). https:\/\/roadbook.com\/opinion\/drug-tourism-retreats-health-hedonism\/"},{"key":"25818_CR29","unstructured":"Winstock, A. R. et al. Global Drug Survey (GDS) 2020: Psychedelics key findings report (2020). https:\/\/www.globaldrugsurvey.com\/gds-2020-psychedelics-report\/"},{"key":"25818_CR30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1097\/NMD.0000000000000828","volume":"206","author":"BS Barnett","year":"2018","unstructured":"Barnett, B. S., Siu, W. O. & Pope, H. G. A survey of American psychiatrists\u2019 attitudes toward classic hallucinogens. J. Nerv. Mental Disease. 206, 476\u2013480 (2018).","journal-title":"J. Nerv. Mental Disease"},{"issue":"4","key":"25818_CR31","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1080\/02791072.2021.1971343","volume":"54","author":"AK Davis","year":"2021","unstructured":"Davis, A. K., Agin-Liebes, G., Espa\u00f1a, M., Pilecki, B. & Luoma, J. Attitudes and beliefs about the therapeutic use of psychedelic drugs among psychologists in the united States. J. Psychoact. Drugs. 54 (4), 309\u2013318 (2021).","journal-title":"J. Psychoact. Drugs"},{"issue":"11","key":"25818_CR32","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/eat.24041","volume":"56","author":"AE Downey","year":"2023","unstructured":"Downey, A. E., Boyd, M., Chaphekar, A. V., Woolley, J. & Raymond-Flesch, M. But the reality is it\u2019s happening: A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy. Int. J. Eat. Disord. 56 (11), 2142\u20132148 (2023).","journal-title":"Int. J. Eat. Disord."},{"issue":"5","key":"25818_CR33","first-page":"449","volume":"32","author":"E Kraiem","year":"2024","unstructured":"Kraiem, E., Diener, M., Guss, J., Mavrides, L. & Saban, S. Psychoanalyst attitudes towards psychedelic-assisted therapy. Drugs: Educ. Prev. Policy. 32(5), 449-460 (2024).","journal-title":"Drugs: Educ. Prev. Policy."},{"key":"25818_CR34","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jad.2022.12.050","volume":"323","author":"P Meir","year":"2023","unstructured":"Meir, P., Taylor, L., Soares, J. C. & Meyer, T. D. Psychotherapists\u2019 openness to engage their patients in Psilocybin-Assisted therapy for mental health treatment. J. Affect. Disord. 323, 748\u2013754 (2023).","journal-title":"J. Affect. Disord"},{"issue":"6","key":"25818_CR35","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1017\/S1478951523001475","volume":"21","author":"R Sholevar","year":"2023","unstructured":"Sholevar, R., Peteet, J., Sanders, J. & Beaussant, Y. Disruption as an opportunity or threat: A qualitative analysis of factors influencing the attitudes of experts in serious illness care toward psychedelic-assisted therapies. Palliat. Support Care. 21 (6), 967\u2013972 (2023).","journal-title":"Palliat. Support Care"},{"key":"25818_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1556\/2054.2023.00294","volume":"8","author":"A Wells","year":"2024","unstructured":"Wells, A., Fernandes, M. & Reynolds, L. Perceptions and attitudes towards psychedelic-assisted psychotherapy among health professionals, patients, and the public: A systematic review. J. Psychedelic Stud. 8, 43\u201362 (2024).","journal-title":"J. Psychedelic Stud."},{"issue":"0","key":"25818_CR37","first-page":"1","volume":"0","author":"C Callon","year":"2021","unstructured":"Callon, C., Williams, M. & Lafrance, A. Meeting the medicine halfway: Ayahuasca ceremony leaders\u2019 perspectives on Preparation and integration practices for participants. J Humanist Psychol. 0(0), 1\u201327 (2021).","journal-title":"J Humanist Psychol."},{"issue":"0","key":"25818_CR38","first-page":"1","volume":"0","author":"M Earleywine","year":"2022","unstructured":"Earleywine, M., Low, F., Lau, C. & De Leo, J. Integration in Psychedelic-Assisted treatments: recurring themes in current providers\u2019 Definitions, Challenges, and concerns. J Humanist Psychol. 0(0), 1\u201318 (2022).","journal-title":"J Humanist Psychol."},{"issue":"4","key":"25818_CR39","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1080\/02791072.2022.2113484","volume":"55","author":"M Williams","year":"2023","unstructured":"Williams, M., Kingston Miller, A., Loizaga-Velder, A., Files, N. & Lafrance, A. Getting to the root: Ayahuasca ceremony leaders\u2019 perspectives on eating disorders. J. Psychoact. Drugs. 55 (4), 425\u2013433 (2023).","journal-title":"J. Psychoact. Drugs"},{"key":"25818_CR40","doi-asserted-by":"crossref","unstructured":"Glynos, N. G. et al. Going underground: Demographics, Services, and best practices endorsed by practitioners providing support for naturalistic psychedelic use. J Psychoact. Drugs, 1\u201311 (2024).","DOI":"10.1080\/02791072.2024.2405685"},{"issue":"3","key":"25818_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1556\/2054.2025.00375","volume":"9","author":"S Hughes","year":"2025","unstructured":"Hughes, S. et al. Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of underground psilocybin mushroom practitioners. J Psychedelic Stud.  9(3), 221-233 (2025).","journal-title":"J Psychedelic Stud."},{"key":"25818_CR42","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1177\/0022167817709585","volume":"57","author":"R Watts","year":"2017","unstructured":"Watts, R., Day, C., Krzanowski, J., Nutt, D. & Carhart-Harris, R. Patients\u2019 accounts of increased connectedness and acceptance after psilocybin for Treatment-Resistant depression. J. Humanist Psychol. 57, 520\u2013564 (2017).","journal-title":"J. Humanist Psychol."},{"key":"25818_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/0269881119897615","volume":"34","author":"GI Agin-Liebes","year":"2020","unstructured":"Agin-Liebes, G. I. et al. Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. J. Psychopharmacol. 34, 155\u2013166 (2020).","journal-title":"J. Psychopharmacol."},{"key":"25818_CR44","doi-asserted-by":"crossref","unstructured":"Garcia-Romeu, A. et al. Persisting reductions in Cannabis, Opioid, and stimulant misuse after naturalistic psychedelic use: an online survey. Front Psychiatry. 10, (2020).","DOI":"10.3389\/fpsyt.2019.00955"},{"key":"25818_CR45","doi-asserted-by":"crossref","unstructured":"Raison, C. L., Jain, R., Penn, A. D., Cole, S. P. & Jain, S. Effects of naturalistic psychedelic use on Depression, Anxiety, and Well-Being: associations with patterns of use, reported Harms, and transformative mental States. Front Psychiatry 13, (2022).","DOI":"10.3389\/fpsyt.2022.831092"},{"key":"25818_CR46","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1177\/00221678211008331","volume":"64","author":"GJ Bathje","year":"2024","unstructured":"Bathje, G. J., Fenton, J., Pillersdorf, D. & Hill, L. C. A qualitative study of intention and impact of Ayahuasca use by Westerners. J. Humanist Psychol. 64, 653\u2013691 (2024).","journal-title":"J. Humanist Psychol."},{"key":"25818_CR47","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1108\/DAT-03-2020-0016","volume":"21","author":"J Pestana","year":"2020","unstructured":"Pestana, J., Beccaria, F. & Petrilli, E. Psychedelic substance use in the Reddit psychonaut community. A qualitative study on motives and modalities. Drugs Alcohol Today. 21, 112\u2013123 (2020).","journal-title":"Drugs Alcohol Today"},{"key":"25818_CR48","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1177\/0269881120936508","volume":"34","author":"CA Roberts","year":"2020","unstructured":"Roberts, C. A., Osborne-Miller, I., Cole, J., Gage, S. H. & Christiansen, P. Perceived harm, motivations for use and subjective experiences of recreational psychedelic \u2018magic\u2019 mushroom use. J. Psychopharmacol. 34, 999\u20131007 (2020).","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"25818_CR49","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1177\/0269881112439253","volume":"26","author":"TS Krebs","year":"2012","unstructured":"Krebs, T. S., Johansen, P. & \u00d8r Lysergic acid diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials. J. Psychopharmacol. 26 (7), 994\u20131002 (2012).","journal-title":"J. Psychopharmacol."},{"key":"25818_CR50","doi-asserted-by":"crossref","unstructured":"Neuhaus, E. C. & Slavich, G. M. Behavioral psychedelics: integrating Mind and behavior to improve health and resilience. Front Psychiatry 13, (2022).","DOI":"10.3389\/fpsyt.2022.821208"},{"key":"25818_CR51","doi-asserted-by":"crossref","unstructured":"van Elk, M. & Yaden, D. B. Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review. Neuroscience Biobehavioral Reviews 140, (2022).","DOI":"10.1016\/j.neubiorev.2022.104793"},{"key":"25818_CR52","doi-asserted-by":"crossref","unstructured":"Ko\u010d\u00e1rov\u00e1, R., Hor\u00e1\u010dek, J. & Carhart-Harris, R. Does psychedelic therapy have a transdiagnostic action and prophylactic potential? Frontiers Psychiatry 12 (2021).","DOI":"10.3389\/fpsyt.2021.661233"},{"key":"25818_CR53","doi-asserted-by":"crossref","unstructured":"Kuiper, H. et al. Psychedelic public health: state of the field and implications for equity. Soc Sci. Med 357, (2024).","DOI":"10.1016\/j.socscimed.2024.117134"},{"key":"25818_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20451253231198466","volume":"13","author":"M van Elk","year":"2023","unstructured":"van Elk, M. & Fried, E. I. History repeating: guidelines to address common problems in psychedelic science. Ther Adv. Psychopharmacol. 13, 1-20 (2023).","journal-title":"Ther Adv. Psychopharmacol."},{"key":"25818_CR55","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World medical association declaration of helsinki: ethical principles for medical research involving human subjects. JAMA 310, 2191\u20132194 (2013).","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1038\/s41598-025-33296-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25818-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25818-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25818-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T01:03:16Z","timestamp":1767056596000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-25818-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25818"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-25818-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-025-33296-w","URL":"https:\/\/doi.org\/10.1038\/s41598-025-33296-w","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41812"}}